Current perspectives on the tumor microenvironment in hepatocellular carcinoma

Area of Science:

• Oncology
• Immunology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a significant cause of cancer-related mortality, characterized by inflammation and a poor prognosis.
• The tumor microenvironment plays a critical role in HCC development and progression, featuring an immunosuppressive milieu and abnormal vasculature.
• Despite advances, effective treatments remain challenging due to the complexity of HCC and its microenvironment.

Purpose of the Study:

• To review the current understanding of the hepatocellular carcinoma (HCC) tumor microenvironment.
• To explore the dynamic interactions between tumor cells, vasculature, immune cells, and the gut.
• To discuss therapeutic strategies focused on manipulating the tumor microenvironment for HCC treatment.

Main Methods:

• This review synthesizes findings from basic and translational research.
• It summarizes pre-clinical and clinical data on targeting the tumor microenvironment in HCC.
• The review analyzes the role of immunosuppressive cells and abnormal tumor vasculature.

Main Results:

• The tumor microenvironment in HCC is characterized by immunosuppression and aberrant vasculature.
• Normalizing the tumor microenvironment through multi-pronged approaches shows promise.
• Interactions between tumor cells, vasculature, and the gut are crucial in HCC progression.

Conclusions:

• Understanding and manipulating the tumor microenvironment is key to advancing HCC therapy.
• Targeting both carcinogenic processes and the immunosuppressive milieu is a viable strategy.
• The evolving landscape of HCC treatment is increasingly shaped by microenvironment-targeted therapies.